Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

CPHI Milan Puts Sustainability to Work, Part 2

BySilvia Forroova

August 14th 2026

PharmTech Weekly Roundup—August 14, 2026

BySusan Haigney

August 14th 2026

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

ByZachary Zubulake

August 14th 2026

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

ByLee Karras,Zachary Zubulake

August 14th 2026

Europe Map with virtual gavel and sound block and AI word. Concept of the EU recently adopted the AI Act, ushering in new restrictions on Artificial Intelligence use cases and mandating transparency | Image Credit: ©tanaonte -stock.adobe.com

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

ByBrian Drapeau

August 13th 2026

July 2004

Articles in this issue

Related Content

CPHI Milan Puts Sustainability to Work, Part 2

PharmTech Weekly Roundup—August 14, 2026

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Trending on Pharmaceutical Technology

PharmTech Weekly Roundup—August 14, 2026

What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.

Q&A: AI Coding Tools Carry the Real Risk